Short Interest in SciSparc Ltd. (NASDAQ:SPRC) Decreases By 66.9%

SciSparc Ltd. (NASDAQ:SPRC) was the target of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 65,200 shares, a decrease of 66.9% from the January 31st total of 197,100 shares. Approximately 0.6% of the shares of the company are sold short. Based on an average daily trading volume, of 8,090,000 shares, the days-to-cover ratio is currently 0.0 days.

SciSparc Stock Down 0.2 %

NASDAQ SPRC opened at $0.37 on Friday. SciSparc has a 52 week low of $0.20 and a 52 week high of $4.10. The stock’s 50-day moving average price is $0.52 and its 200-day moving average price is $0.36.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.